Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis

Fourteen patients suffering from American cutaneous leishmaniasis were studied. Assays of the lymphocyte proliferative response induced in vitro by Leishmania braziliensis antigens were performed. After 5 days in culture, L. braziliensis-stimulated blast T cells were harvested for CD4+ and CD8+ phenotype analysis. When results before and at the end of therapy were compared, leishmaniasis patients showed an increase in the percentage of CD8+ blast T cells and a decline in the proportion of CD4+ blast T cells in cultures. The levels of gamma interferon in T-cell culture supernatants showed a tendency to increase when the patients were cured. These results show a pattern of higher proportions of Leishmania-reactive CD8+ T cells and lower proportions of Leishmania-reactive CD4+ T cells after cure.

[1]  S. Hoffman,et al.  Induction of cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein by immunization with soluble recombinant protein without adjuvant , 1993, Infection and immunity.

[2]  K. Lohman,et al.  Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection , 1993, Infection and immunity.

[3]  W. Morrow,et al.  Can soluble antigens induce CD8+ cytotoxic T-cell responses? A paradox revisited. , 1993, Immunology today.

[4]  P. Romero,et al.  The Analysis of the Function and Specificity of T Cells Triggered During Infection with Leishmania , Its Importance for the Rational Design of a Vaccine , 1993 .

[5]  H. Bielefeldt-Ohmann,et al.  Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. , 1992, Science.

[6]  P. Scott.  IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. , 1991, Journal of immunology.

[7]  D. Russell,et al.  The interaction between CD8+ cytotoxic T cells and Leishmania-infected macrophages , 1991, The Journal of experimental medicine.

[8]  H. Momen,et al.  Characterization and classification of leishmanial parasites from humans, wild mammals, and sand flies in the Amazon region of Brazil. , 1991, The American journal of tropical medicine and hygiene.

[9]  J. Louis,et al.  Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells. , 1991, International immunology.

[10]  C. Pirmez,et al.  Immunologic responsiveness in American cutaneous leishmaniasis lesions. , 1990, Journal of immunology.

[11]  H. Moll,et al.  Resistance to murine cutaneous leishmaniasis is mediated by TH1 cells, but disease‐promoting CD4+ cells are different from TH2 cells , 1990, European journal of immunology.

[12]  H. Teh,et al.  Immunoprotective Leishmania major synthetic T cell epitopes , 1990, The Journal of experimental medicine.

[13]  J V Giorgi,et al.  Application of flow cytometry to the study of HIV infection. , 1990, AIDS.

[14]  A. White,et al.  Prophylactic immunization against experimental Leishmania donovani infection by use of a purified protein vaccine. , 1990, The Journal of infectious diseases.

[15]  C. Pirmez,et al.  Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis , 1990, Clinical and experimental immunology.

[16]  M. Belosevic,et al.  Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. , 1989, Journal of immunology.

[17]  W. Chan,et al.  Macrophage activation by interferon‐γ from host‐protective T cells is inhibited by interleukin (IL) 3 and IL 4 produced by disease‐promoting T cells in leishmaniasis , 1989, European journal of immunology.

[18]  J. Convit,et al.  Cell‐mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapy , 1989, Parasite immunology.

[19]  M. Awwad,et al.  Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania , 1989, The Journal of experimental medicine.

[20]  F. Liew.  Functional heterogeneity of CD4+ T cells in leishmaniasis. , 1989, Immunology today.

[21]  J. Convit,et al.  T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis , 1988, Journal of clinical microbiology.

[22]  F. Conceição-Silva,et al.  Quantification of Leishmania-specific T cells in human American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) by limiting dilution analysis. , 1988, Clinical and experimental immunology.

[23]  M. Ulrich,et al.  IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN LOCALISED CUTANEOUS LEISHMANIASIS , 1987, The Lancet.

[24]  P. Vassalli,et al.  Involvement of specific Lyt‐2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis , 1987, European journal of immunology.

[25]  R. Locksley,et al.  Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets. , 1987, Annales de l'Institut Pasteur. Immunology.

[26]  C. Antunes,et al.  Controlled field trials of a vaccine against New World cutaneous leishmaniasis. , 1986, International journal of epidemiology.

[27]  C. Pirmez,et al.  Human american cutaneous leishmaniasis (Leishmania b. braziliensis) in Brazil: lymphoproliferative responses and influence of therapy. , 1986, Clinical and experimental immunology.

[28]  R. Titus,et al.  Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice. , 1986, Journal of immunology.

[29]  R. Locksley,et al.  Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. , 1986, Journal of immunology.

[30]  S. Reed,et al.  Cell mediated immunity in American cutaneous and mucosal leishmaniasis. , 1985, Journal of immunology.

[31]  R. Titus,et al.  Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. , 1985, Journal of immunology.

[32]  J. Louis,et al.  Induction by specific T lymphocytes of intracellular destruction of Leishmania major in infected murine macrophages , 1984, Parasite immunology.

[33]  R. Zubler,et al.  The in vitro Generation and Functional Analysis of Murine T Cell Populations and Clones Specific for a Protozoan Parasite, Leishmania tropica , 1982, Immunological reviews.

[34]  C. Hale,et al.  Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica , 1980, The Journal of experimental medicine.